BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30766478)

  • 1. Electrical Abnormalities in Dopaminergic Neurons of the Substantia Nigra in Mice With an Aromatic L-Amino Acid Decarboxylase Deficiency.
    Ho SY; Chien YH; Tsai LK; Muramatsu SI; Hwu WL; Liou HH; Lee NC
    Front Cell Neurosci; 2019; 13():9. PubMed ID: 30766478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual effects of L-DOPA on nigral dopaminergic neurons.
    Guatteo E; Yee A; McKearney J; Cucchiaroni ML; Armogida M; Berretta N; Mercuri NB; Lipski J
    Exp Neurol; 2013 Sep; 247():582-94. PubMed ID: 23481547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamatergic synaptic currents of nigral dopaminergic neurons follow a postnatal developmental sequence.
    Pearlstein E; Gouty-Colomer LA; Michel FJ; Cloarec R; Hammond C
    Front Cell Neurosci; 2015; 9():210. PubMed ID: 26074777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential contribution of Ih to the integration of excitatory synaptic inputs in substantia nigra pars compacta and ventral tegmental area dopaminergic neurons.
    Masi A; Narducci R; Resta F; Carbone C; Kobayashi K; Mannaioni G
    Eur J Neurosci; 2015 Nov; 42(9):2699-706. PubMed ID: 26354486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the dopaminergic system in a murine model of aromatic L-amino acid decarboxylase deficiency.
    Lee NC; Shieh YD; Chien YH; Tzen KY; Yu IS; Chen PW; Hu MH; Hu MK; Muramatsu S; Ichinose H; Hwu WL
    Neurobiol Dis; 2013 Apr; 52():177-90. PubMed ID: 23275025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subthalamic stimulation-induced synaptic responses in substantia nigra pars compacta dopaminergic neurons in vitro.
    Iribe Y; Moore K; Pang KC; Tepper JM
    J Neurophysiol; 1999 Aug; 82(2):925-33. PubMed ID: 10444687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraquat inhibits postsynaptic AMPA receptors on dopaminergic neurons in the substantia nigra pars compacta.
    Lee CY; Lee CH; Shih CC; Liou HH
    Biochem Pharmacol; 2008 Oct; 76(9):1155-64. PubMed ID: 18761327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal Development of Glutamatergic Synapses Afferent to Dopaminergic Neurons of the Pink1(-/-) Mouse Model of Parkinson's Disease.
    Pearlstein E; Michel FJ; Save L; Ferrari DC; Hammond C
    Front Cell Neurosci; 2016; 10():168. PubMed ID: 27445695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Control of Dopaminergic Excitability and Locomotion by Cholinergic Inputs in Mouse Substantia Nigra.
    Estakhr J; Abazari D; Frisby K; McIntosh JM; Nashmi R
    Curr Biol; 2017 Jul; 27(13):1900-1914.e4. PubMed ID: 28648825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topographic heterogeneity of substantia nigra neurons: diversity in intrinsic membrane properties and synaptic inputs.
    Hajós M; Greenfield SA
    Neuroscience; 1993 Aug; 55(4):919-34. PubMed ID: 7901802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiological Characterization of Novel Effects of the Uptake-2 Blocker Decynium-22 (D-22) on Dopaminergic Neurons in the Substantia Nigra Pars Compacta.
    Lloyd JT; Martini A; McDouall A; Sood R; Freestone PS; Mercuri NB; Lipski J
    Neuroscience; 2019 Jan; 396():154-165. PubMed ID: 30447392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E receptor EP1 enhances GABA-mediated inhibition of dopaminergic neurons in the substantia nigra pars compacta and regulates dopamine level in the dorsal striatum.
    Tanaka Y; Furuyashiki T; Momiyama T; Namba H; Mizoguchi A; Mitsumori T; Kayahara T; Shichi H; Kimura K; Matsuoka T; Nawa H; Narumiya S
    Eur J Neurosci; 2009 Dec; 30(12):2338-46. PubMed ID: 20092576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine Inhibition Differentially Controls Excitability of Substantia Nigra Dopamine Neuron Subpopulations through T-Type Calcium Channels.
    Evans RC; Zhu M; Khaliq ZM
    J Neurosci; 2017 Mar; 37(13):3704-3720. PubMed ID: 28264982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscarine reduces calcium-dependent electrical activity in substantia nigra dopaminergic neurons.
    Scroggs RS; Cardenas CG; Whittaker JA; Kitai ST
    J Neurophysiol; 2001 Dec; 86(6):2966-72. PubMed ID: 11731553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presynaptic facilitation of glutamatergic synapses to dopaminergic neurons of the rat substantia nigra by endogenous stimulation of vanilloid receptors.
    Marinelli S; Di Marzo V; Berretta N; Matias I; Maccarrone M; Bernardi G; Mercuri NB
    J Neurosci; 2003 Apr; 23(8):3136-44. PubMed ID: 12716921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperative synthesis of dopamine by non-dopaminergic neurons as a compensatory mechanism in the striatum of mice with MPTP-induced Parkinsonism.
    Kozina EA; Kim AR; Kurina AY; Ugrumov MV
    Neurobiol Dis; 2017 Feb; 98():108-121. PubMed ID: 27940203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible roles of kainate receptors on GABAergic nerve terminals projecting to rat substantia nigra dopaminergic neurons.
    Nakamura M; Jang IS; Ishibashi H; Watanabe S; Akaike N
    J Neurophysiol; 2003 Sep; 90(3):1662-70. PubMed ID: 12789017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excitatory drive from the Subthalamic nucleus attenuates GABAergic transmission in the Substantia Nigra pars compacta via endocannabinoids.
    Freestone PS; Wu XH; de Guzman G; Lipski J
    Eur J Pharmacol; 2015 Nov; 767():144-51. PubMed ID: 26472124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Action potential and calcium dependence of tonic somatodendritic dopamine release in the Substantia Nigra pars compacta.
    Yee AG; Forbes B; Cheung PY; Martini A; Burrell MH; Freestone PS; Lipski J
    J Neurochem; 2019 Feb; 148(4):462-479. PubMed ID: 30203851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SK channel function regulates the dopamine phenotype of neurons in the substantia nigra pars compacta.
    Aumann TD; Gantois I; Egan K; Vais A; Tomas D; Drago J; Horne MK
    Exp Neurol; 2008 Oct; 213(2):419-30. PubMed ID: 18680743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.